220
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Predictors of Late Presentation for HIV/AIDS in West Arsi Zone Public Health Institutions, South Ethiopia: Unmatched Case–Control Study

ORCID Icon, ORCID Icon, , ORCID Icon, , ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 759-766 | Published online: 13 Jul 2021

References

  • Antinori A, Coenen T, Costagiola D, et al. Late presentation of HIV infection: a consensus definition. HIV Med. 1201;12:61–64. doi:10.1111/j.1468-1293.2010.00857.x
  • Waldrop G. Stable patients and patients with advanced disease: consensus definitions to support sustained scale up of antiretroviral therapy. Trop Med Int Health. 2016;1:1–8.
  • Kozak M. Review Late diagnosis, delayed presentation and late presentation in HIV: proposed definitions, methodological considerations and health implications. Int Med Press. 2013;18:17–23.
  • Nyika H. Factors associated with late presentation for HIV/AIDS care in Harare City, Zimbabwe. BMC Public Health. 2015;16(369):1–7.
  • UNAIDS. Global HIV and AIDS statistics; 2018.
  • UNAIDS. Global HIV and AIDS statistics; 2017.
  • Beck EJ. The cost-effectiveness of highly active antiretroviral therapy. Canada. 2004;18:2411–2418.
  • Krentz H, Gill M. Cost of medical care for HIV-infected patients within a regional population from 1997 to 2006. HIV Med. 2008;9:721–730. doi:10.1111/j.1468-1293.2008.00613.x
  • Wang H. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980 – 2015: the Global Burden of Disease Study. Lancet HIV. 2016;3:361–387.
  • Jeong S, Italiano C, Chaiwarith R. Late Presentation into Care of HIV Disease and Its Associated Factors in Asia. AIDS Res Hum Retroviruses.2016;32(3):255–261. doi:10.1089/aid.2015.0058
  • Abebe N. Survival status of HIV positive adults on antiretroviral treatment in Debre Markos Referral Hospital, Northwest Ethiopia: retrospective cohort study. Pan African Med J. 2014;8:1–13.
  • Belay G, Endalamaw A, Ayele A. Late presentation of HIV positive adults and its predictors to HIV/AIDS care in Ethiopia: a systematic review and meta-analysis. BMC Infect Dis. 2019;19(534):1–8.
  • Gesesew H, Ward P, Woldemichael K, et al. Late presentation for HIV care in Southwest Ethiopia in 2003–2015: prevalence, trend, outcomes and risk factors. BMC Infect Dis. 2018;18(19):1–11. doi:10.1186/s12879-018-2971-6
  • Kigozi I. Late disease stage at presentation to an HIV clinic in the era of free antiretroviral therapy in sub-Saharan Africa. J Acquir Immune Defic Syndr. 2010;52(2):1–21.
  • Mocroft A. Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). Plos Med. 2013;10(9).
  • Sobrino-vegas P, Moreno S, Rubio R, et al. Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort. j Infect. 2016;72:587–596. doi:10.1016/j.jinf.2016.01.017
  • Meyer-rath G, Over M, Bangsberg DR. HIV Treatment as Prevention: modelling the Cost of Antiretroviral Treatment — state of the Art and Future Directions. PLoS Med. 2012;9(7):1–6. doi:10.1371/journal.pmed.1001247
  • Tshabangu N, Mohapi L, Rosen S. NIH Public Access. J Acquir Immune Defic Syndr. 2014;62(3):322–328.
  • Alvarez-uria G. Factors Associated with Late Presentation of HIV and Estimation of Antiretroviral Treatment Need according to CD4 Lymphocyte Count in a Resource-Limited Setting: A cohort study in India. Interdiscip Perspec Infect Dis.. 2016;9(3):1–8.
  • Coul E, van Sighem A, Brinkman K, et al. Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996 – 2014: results from a national observational cohort. BMJ Open. 2016;6:e009688. doi:10.1136/bmjopen-2015-009688
  • Gesesew H, Tesfamichael F, Adamu B. Factors Affecting Late Presentation for HIV/AIDS Care in Southwest Ethiopia: a Case Control Study. Public Health Res. 2013;3(4):98–107.
  • Darcis G. Factors associated with late presentation for HIV care in a single Belgian reference center; 2018:2006–2017.
  • Krentz H, Gil M. Increased costs of HIV care associated with aging in an HIV-infected population. HIV Med. 2015;16:38–47. doi:10.1111/hiv.12176
  • Hermans L. Delayed HIV testing in internal medicine clinics – a missed opportunity. J Med. 2012;70(2):69–73.
  • Fomundam HN. Prevalence and predictors of late presentation for HIV care in South Africa. Sam j. 2017;107(12):1058–1064.
  • Abaynew Y, Deribew A, Deribe K. Factors associated with late presentation to HIV/AIDS care in South Wollo ZoneEthiopia: a case-control study. AIDS Res Ther. 2011;8(8):4–9. doi:10.1186/1742-6405-8-8
  • Gelaw YA, Senbete GH, Adane AA, et al. Determinants of late presentation to HIV/AIDS care in Southern Tigray Zone, Northern Ethiopia: an institution based case – control study. AIDS Res Ther. 2015;12(40):1–8. doi:10.1186/s12981-015-0079-2